Logo

Dr. Reddy's to Acquire a Portfolio of 42 Abbreviated New Drug Applications (ANDA) in the US

Share this

Dr. Reddy's to Acquire a Portfolio of 42 Abbreviated New Drug Applications (ANDA) in the US

Shots:

  • Dr. Reddy’s acquires a portfolio of 42 approved- non-marketed Abbreviated New Drug Applications (ANDAs) in the US- including >30 generics injectable
  • The focus of the acquisition is to enhance Dr. Reddy’s injectable portfolio in the US and globally
  • Dr. Reddy’s will launch the products within the next one to two years and according to IQVIA the products produced ~$645M revenue in 2018 in the US 

Ref: Dr. Reddy's | Image: Twitter

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions